IE 11 is not supported. For an optimal experience visit our site on another browser.

InoLife Technologies Addresses Quotation of the Company's Common Stock

/ Source: GlobeNewswire

RALEIGH, N.C., Feb. 25, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL), a service based healthcare products development, integration and marketing company, advises shareholders that they can access quotations, including level 2 data and other information at: . InoLife is on the OTCQB tier at OTC Markets, which includes OTC Bulletin Board securities and other SEC reporting issuers.

Due to the popularity of the OTC Markets system many Market Makers no longer provide quotes on the OTCBB system and only through the OTC Markets systems. This quote is not picked up by all quotation services. This issue does not reflect upon the securities affected, including InoLife Technologies, Inc.

InoLife continues to be in compliance with its SEC reporting requirements.

InoLife is monitoring the quotation situation. In addition to accurate quotes appear to be available at

About InoLife Technologies, Inc.

InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies,, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company's mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife's products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally, InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.

Forward-Looking Statements

Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

CONTACT: Henry Harrison IR Pro 2.0, Inc. 407-862-5151